# ![@atai_life Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1009807192445390848.png) @atai_life atai Life Sciences

atai Life Sciences posts on X about health, mental health, we are, update the most. They currently have [------] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.

### Engagements: [--] [#](/creator/twitter::1009807192445390848/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1009807192445390848/c:line/m:interactions.svg)

- [--] Week [--] -55%
- [--] Month [-----] -100%
- [--] Months [----------] +144%
- [--] Year [----------] +285,396%

### Mentions: [--] [#](/creator/twitter::1009807192445390848/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1009807192445390848/c:line/m:posts_active.svg)

- [--] Month [--] -54%
- [--] Months [--] +414%
- [--] Year [--] +443%

### Followers: [------] [#](/creator/twitter::1009807192445390848/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1009807192445390848/c:line/m:followers.svg)

- [--] Week [------] +0.01%
- [--] Month [------] -0.07%
- [--] Months [------] +3.60%
- [--] Year [------] +11%

### CreatorRank: undefined [#](/creator/twitter::1009807192445390848/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1009807192445390848/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance)  [countries](/list/countries)  [travel destinations](/list/travel-destinations)  [exchanges](/list/exchanges)  [social networks](/list/social-networks)  [technology brands](/list/technology-brands)  [cryptocurrencies](/list/cryptocurrencies)  [celebrities](/list/celebrities) 

**Social topic influence**
[health](/topic/health), [mental health](/topic/mental-health), [we are](/topic/we-are), [update](/topic/update), [release](/topic/release), [atai life](/topic/atai-life) #25, [2a](/topic/2a), [$atai](/topic/$atai) #29, [ceo](/topic/ceo), [key](/topic/key)

**Top accounts mentioned or mentioned by**
[@flobrand](/creator/undefined) [@beckleypsytech](/creator/undefined) [@cangermayer](/creator/undefined) [@compasspathway](/creator/undefined) [@srinigrao](/creator/undefined) [@c_angermayer](/creator/undefined) [@beckleypsytechs](/creator/undefined) [@massgeneralnews](/creator/undefined) [@allanmalievsky](/creator/undefined) [@atailife](/creator/undefined) [@saltconference](/creator/undefined) [@mghneurology](/creator/undefined) [@nih](/creator/undefined) [@nidanews](/creator/undefined) [@nasdaq](/creator/undefined) [@maps](/creator/undefined) [@psychedvantage](/creator/undefined) [@proactive_x](/creator/undefined) [@mindmedcos](/creator/undefined) [@jamonrahn](/creator/undefined)

**Top assets mentioned**
[Atai Life Sciences B.V. (ATAI)](/topic/atai-life) [sETH (SETH)](/topic/$seth)
### Top Social Posts
Top posts by engagements in the last [--] hours

"What a group ;) Our own @C_Angermayer @mindmedco's @JamonRahn @foundrygroup's @sether and hosted by @BlackLabSports' @jp_obrien Let's dig into #psychedelics for #mentalhealth (#depression #anxiety and #addiction)"  
[X Link](https://x.com/atai_life/status/1260257490916147200)  2020-05-12T17:16Z 12.2K followers, [--] engagements


"Our Founder & Chairman @C_Angermayer is talking today at renowned US @SALTConference - testament to the growing psychedelic renaissance & broadening interest in the potential of #psychedelics in the future of #mentalhealth treatment. #OpenYourMind #ApeironInvestments"  
[X Link](https://x.com/anyuser/status/1437737956601704450)  2021-09-14T11:20Z 13.5K followers, [--] engagements


"Today we announced results from the Kures Therapeutics Phase [--] Part [--] clinical trial of KUR-101 a deuterated derivative of mitragynine for the potential treatment of #opioidusedisorder cc @flobrand @C_Angermayer @Allan_Malievsky sub #mentalhealth #oud https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-results-kures-therapeutics-phase-1 https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-results-kures-therapeutics-phase-1"  
[X Link](https://x.com/anyuser/status/1606276895565402118)  2022-12-23T13:13Z 13.5K followers, [----] engagements


"It was great to hear from our Senior Vice President of Early Development Glenn Short at the @BostonDOT conference this week. Glenns presentation on AI-assisted/structure-based drug design is just one example of how at atai we are leveraging cutting-edge technology to accelerate drug discovery in order to bring the next generation of mental health treatments to patients as efficiently and effectively as possible. #mentalhealth #BostonDOT23 #psychedelics #AI"  
[X Link](https://x.com/atai_life/status/1707676517625409932)  2023-09-29T08:39Z 12K followers, [----] engagements


"Today we announced the completion of the Phase [--] study of VLS-01 (DMT) in healthy participants. Our CEO and Co-Founder @Flobrand commented: We are pleased to report the completion of the Phase [--] study of VLS-01 in which we demonstrated a supportive PK/PD profile of our proprietary OTF formulation of DMT. We plan to test a further optimized version of our OTF formulation in a forthcoming Phase 1b prior to initiating a Phase [--] study in TRD. Read more: #Biotech #MentalHealth https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-completion-phase-1-study-vls-01"  
[X Link](https://x.com/anyuser/status/1708940640321462489)  2023-10-02T20:22Z 13.5K followers, [----] engagements


"Read Jordan M. Osmond et al. Etifoxine inhibits NLRP3 inflammasome activity in human and murine myeloid cells here:"  
[X Link](https://x.com/atai_life/status/1712774340725362790)  2023-10-13T10:16Z 11.9K followers, [---] engagements


"For more on NLRP3 as a potential target read the following article:"  
[X Link](https://x.com/atai_life/status/1712774342390538527)  2023-10-13T10:16Z 12K followers, [---] engagements


"We are pleased to share our Q3 [----] update demonstrating the progress weve made in pursuit of our mission to heal mental health disorders. We advanced our key clinical programs such as RL-007 VLS-01 and EMP-01 and continued to drive forward our drug discovery and preclinical work such as on our EG-X compounds. With a strong cash balance of $209M and our dedicated team we are well-positioned to continue advancing our programs towards upcoming milestones. Read more: $ATAI #MentalHealth #Biotech #MentalHealthResarch #Q3 #Earnings"  
[X Link](https://x.com/anyuser/status/1724399728425570775)  2023-11-14T12:11Z 13.5K followers, [----] engagements


"Thrilled to announce our strategic investment in and collaboration with @BeckleyPsytech bringing two clinical-stage psychedelic assets into the atai mental health innovation platform. Join the webcast with our executive team today at 8am ET today to learn more. Full press release here: https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-strategic-investment-beckley https://edge.media-server.com/mmc/p/astec47k/ https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-strategic-investment-beckley"  
[X Link](https://x.com/anyuser/status/1742892851275423847)  2024-01-04T12:56Z 13.5K followers, [----] engagements


"ICYMI: Last week we announced a strategic investment in @BeckleyPsytech underscoring our conviction in psychedelics to transform the landscape of mental health treatments. As covered by Bloomberg the deal brings two patent-protected clinical-stage short-duration psychedelic assets into the atai platform reinforcing our #psychedelics portfolio as the largest and most diverse in biopharma. https://www.bloomberg.com/news/articles/2024-01-04/thiel-backed-psychedelic-firm-atai-said-to-buy-stake-in-beckley"  
[X Link](https://x.com/anyuser/status/1744370808745533524)  2024-01-08T14:49Z 13.5K followers, [----] engagements


"1 in [--] people on #Medicare have a #mentalhealth condition yet 50% receive care. So we're delighted to see new reimbursement guidelines which mean that licensed therapists are now eligible for reimbursement. A positive step towards making mental health treatment accessible for everyone everywhere. #patientaccess"  
[X Link](https://x.com/atai_life/status/1750938370056864139)  2024-01-26T17:46Z 11.9K followers, [---] engagements


"For many talking - whether its with a trusted friend family member or mental health professional - can be an important part of healing. We applaud organizations like @MindCharity @Rethink_ and @samaritans who champion the importance of getting help and provide vital support on days like today and every day. With our research into psychedelic medicines combined with talking therapies we want to change mental health treatment forever. Tell us how has talking helped you #TimetoTalk"  
[X Link](https://x.com/atai_life/status/1753022277422100580)  2024-02-01T11:47Z 12K followers, [---] engagements


"Next week our CEO & Co-Founder @flobrand will take part in a panel titled Partnering with Industry on CNS Neuroscience Drug Development at Bio Neuroscience in Amsterdam Netherlands. The session will explore how collaboration and innovation can help to accelerate the development of novel treatments for neuropsychiatric conditions such as schizophrenia and major depressive disorder. Were looking forward to taking part in this summit with other leaders and innovators in CNS neuroscience and psychiatric drug development. #BioNeuroscience #CNS #MentalHealth"  
[X Link](https://x.com/atai_life/status/1754527412019155006)  2024-02-05T15:28Z 12K followers, [---] engagements


"A new report from @CrisisTextLine and @commongoodlabs reveals that young people in the US experiencing a mental health crisis turn to social connection music and the arts as their primary coping mechanisms. As a result of an analysis of over [-----] conversations with young people in crisis they revealed a set of resources that helped them to cope. These included: ➡ Opportunities for social connection: Participating in clubs and spending time with friends. ➡ Exercise and sports: Physical activity boosts mood and provides healthy coping mechanisms. ➡ Mental health services: Access to"  
[X Link](https://x.com/atai_life/status/1758159575243472901)  2024-02-15T16:01Z 12K followers, [---] engagements


"Today we shared our [----] full year financial results and business highlights. Our CEO @FloBrand commented: In [----] we demonstrated our continued commitment to transforming mental health care for those most in need. Much of our recent focus has centered on developing psychedelic-based therapies for depression that require two hours or less in a clinic. We believe that the combination of a short treatment time and durable efficacy has the potential to enable accessible and convenient interventional treatments at scale. Read the full press release:"  
[X Link](https://x.com/atai_life/status/1773326909339844818)  2024-03-28T12:30Z 12.1K followers, [---] engagements


"Next week we will be at the @HorizonsPBC conference in NYC . On Friday May [--] our Co-Founder and Chief Scientific Officer @SriniGRao will participate in a fireside chat on the topic of Therapy therapeutics and psychedelics. For more info visit: https://www.horizonspbc.com/newyork https://www.horizonspbc.com/newyork https://www.horizonspbc.com/newyork https://www.horizonspbc.com/newyork"  
[X Link](https://x.com/atai_life/status/1786048174542528571)  2024-05-02T15:00Z 12.1K followers, [----] engagements


"Were pleased to welcome Scott Braunstein M.D. and Laurent Fischer M.D. @BiotechFischer as new independent directors of our Board. Their wealth of expertise in biopharma will be pivotal in shaping our mission to transform mental health treatment. Full press release: https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-strengthens-board-appointment-two-new https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-strengthens-board-appointment-two-new"  
[X Link](https://x.com/atai_life/status/1793599121925738983)  2024-05-23T11:05Z 12.1K followers, [----] engagements


"Q3 #Earnings update: IND cleared for VLS-01 with Phase [--] in TRD initiating around YE24. Also on track for Phase [--] study of EMP-01 in SAD. Exciting momentum as we drive mental health innovation forward. Full press release: https://buff.ly/3UKSBqI https://buff.ly/3UKSBqI"  
[X Link](https://x.com/anyuser/status/1856698579433447469)  2024-11-13T14:00Z 13.5K followers, [----] engagements


"Milestone update: Enrollment complete in Ph2b trial of @BeckleyPsytech's BPL-003 for treatment-resistant depression (TRD). Results expected mid-2025. Full announcement here: http://bit.ly/4immzun http://bit.ly/4immzun"  
[X Link](https://x.com/anyuser/status/1897277094629138585)  2025-03-05T13:24Z 13.5K followers, [----] engagements


"Q4 #Earnings highlights: Strong financial position following successful capital raise with two Phase [--] trials underway & large Phase 2b results expected mid-2025. 🔗 #MentalHealth http://bit.ly/4ioeENc http://bit.ly/4ioeENc"  
[X Link](https://x.com/anyuser/status/1901609732940444021)  2025-03-17T12:21Z 13.5K followers, [----] engagements


"Every day over [---] million people face the struggle of depression. [--] in [--] find no relief in current treatment options. For those living with treatment-resistant depression hope feels out of reach. We're proud to share the next video in our #OneBillionPeople series highlighting the challenges of living with TRD. #MentalHealth"  
[X Link](https://x.com/anyuser/status/1854154406029078907)  2024-11-06T13:30Z 13.5K followers, [----] engagements


"#Q3 2025: a transformational quarter for AtaiBeckley Highlights: ✅ BPL-003 received Breakthrough Therapy designation by the U.S. FDA for treatment-resistant depression ✅Reported positive Phase 2a and Phase 2b open-label extension data for BPL-003 Full update: #Q3 #Earnings https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-reports-third-quarter-2025-financial-results-and https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-reports-third-quarter-2025-financial-results-and"  
[X Link](https://x.com/anyuser/status/1988578780412367262)  2025-11-12T12:05Z 13.5K followers, 10.6K engagements


"This #MensMentalHealthMonth were highlighting a stark reality: fewer than half of men struggling with depression or anxiety will seek treatment. For many stigma remains a major barrier. At AtaiBeckley were working to create a world with new possibilities for mental health"  
[X Link](https://x.com/ataibeckley/status/1991167193384669361)  2025-11-19T15:30Z 13.5K followers, [----] engagements


"Proud to announce a newly granted U.S. patent for EMP-01 (oral R-MDMA) which further reinforces our innovation and long-term IP protection. Read more: https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-announces-new-us-patent-granted-emp-01-strengthening https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-announces-new-us-patent-granted-emp-01-strengthening"  
[X Link](https://x.com/ataibeckley/status/1999235693864784087)  2025-12-11T21:51Z 13.5K followers, [---] engagements


"AtaiBeckley was at #ACNP2026 We presented new data on BPL-003 including a Hot Topic talk + poster from Dr. David Feifel and a preclinical poster from Dr. Michelle Kokkinou. We enjoyed sharing our work with the scientific community. Read more below: https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-participates-64th-annual-acnp-meeting-two-scientific https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-participates-64th-annual-acnp-meeting-two-scientific"  
[X Link](https://x.com/ataibeckley/status/2012135111937179799)  2026-01-16T12:09Z 13.5K followers, [---] engagements


"#BlueMonday is often called the most depressing day of the year - but mental health challenges dont just happen on one day. We need better support less stigma and more effective treatments - today and every day. #MentalHealthAwareness #BlueMonday2026 #TransformingMentalHealth #MentalHealthSupport https://twitter.com/i/web/status/2013215657391796427 https://twitter.com/i/web/status/2013215657391796427"  
[X Link](https://x.com/ataibeckley/status/2013215657391796427)  2026-01-19T11:43Z 13.5K followers, [---] engagements


"Our CEO & Co-Founder @SriniGRao will be speaking at the RBC Capital Markets MiniSymposium on Psychedelic Clinical Studies today. He will join a panel alongside leaders from Reunion Neuroscience and Helus Pharma to discuss how to plan and conduct psychedelic studies for clinical and regulatory success. Looking forward to the conversation. #Biotech #Psychedelics #ClinicalTrials https://twitter.com/i/web/status/2014311066855985349 https://twitter.com/i/web/status/2014311066855985349"  
[X Link](https://x.com/ataibeckley/status/2014311066855985349)  2026-01-22T12:15Z 13.5K followers, [---] engagements


"#News: atai Life Sciences & @BeckleyPsytech have combined to form atai Beckley Creating a global leader in psychedelic mental health therapies #mentalhealth therapies. Together were accelerating innovation for those in need. Learn more: Join our conference call at 8am ET: #ataibeckley #Biotech https://events.q4inc.com/attendee/298405838 https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-combine-creating-global https://events.q4inc.com/attendee/298405838"  
[X Link](https://x.com/ataibeckley/status/1929490755174662184)  2025-06-02T10:50Z 13.5K followers, 11.1K engagements


"#Q2 [----] highlights: ✅Announced atais strategic combination with @BeckleyPsytech ✅Reported positive topline data in BPL-003 for treatment-resistant depression Full update: #MentalHealth #Biotech #Earnings https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-reports-second-quarter-2025-financial-results https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-reports-second-quarter-2025-financial-results"  
[X Link](https://x.com/anyuser/status/1955989770418708820)  2025-08-14T13:47Z 13.5K followers, [----] engagements


"Were proud to support @MGHNeurology and their Center for the Neuroscience of Psychedelics. The atai Research #Fellowship is designed to help graduate students pursue cutting-edge research in mental health. #MentalHealthInnovation https://www.youtube.com/watchv=5BsVrWbWYYk https://www.youtube.com/watchv=5BsVrWbWYYk"  
[X Link](https://x.com/ataibeckley/status/1958933356512780671)  2025-08-22T16:44Z 13.5K followers, [----] engagements


"#News #Investors: Tackling the opioid use crisis requires bold innovation. Were proud to have been awarded a grant worth up to $11.4 million from @NIH to fund the development of novel treatment options. #MentalHealthInnovation @NIDAnews https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-awarded-grant-national-institutes-health https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-awarded-grant-national-institutes-health"  
[X Link](https://x.com/ataibeckley/status/1968717706946899990)  2025-09-18T16:44Z 13.5K followers, [----] engagements


"#News: atai Life Sciences $ATAI & @BeckleyPsytech announce results from the open-label Phase 2a study of BPL-003 in treatment-resistant depression. Read more: https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-report-positive-phase-2a https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-report-positive-phase-2a"  
[X Link](https://x.com/anyuser/status/1970444055311192406)  2025-09-23T11:04Z 13.5K followers, 112.6K engagements


"Yesterday $atai filed a Form S-3. A shelf registration statement is ordinary course - replacing a previous shelf registration statement - we were also able to fulfill a contractual obligation to register (already issued) shares from the two private (previously closed) placements from June and July [----]. No new shares were issued as a result of this filing. https://twitter.com/i/web/status/1973029758817493269 https://twitter.com/i/web/status/1973029758817493269"  
[X Link](https://x.com/ataibeckley/status/1973029758817493269)  2025-09-30T14:18Z 13.5K followers, [----] engagements


"#News: Were thrilled to announce the successful completion of atai Life Sciences strategic combination with Beckley Psytech. Together we are now AtaiBeckley a global leader in transformative mental health therapies. Read the press release here: https://ir.ataibeckley.com/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-announce-successful https://ir.ataibeckley.com/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-announce-successful"  
[X Link](https://x.com/anyuser/status/1986042290083958930)  2025-11-05T12:05Z 13.5K followers, 17.2K engagements


"AtaiBeckley lights up the @NASDAQ tower in Times Square The combination of atai Life Sciences & @BeckleyPsytech marks a major step forward for patients and the mental health care industry. Were excited for whats ahead and grateful to everyone who has supported us along the way. https://twitter.com/i/web/status/1986837549516792243 https://twitter.com/i/web/status/1986837549516792243"  
[X Link](https://x.com/anyuser/status/1986837549516792243)  2025-11-07T16:46Z 13.5K followers, [----] engagements


"Were proud to see our team contributing to the growing community of researchers dedicated to advancing psychedelic science in Canada. Tune in today to see Hailey Gilmore Clinical Development Liaison at AtaiBeckley discuss our latest clinical development progress at the @MAPSCanada Canada Research Room. #PsychedelicResearch #MentalHealth #AtaiBeckley"  
[X Link](https://x.com/ataibeckley/status/2016916650461982918)  2026-01-29T16:49Z 13.5K followers, [----] engagements


"The psychedelics sector is hitting a 'tipping point' in [----]. We're proud to be featured in this @biospace article highlighting the companies progressing late-stage programs towards patients in need. With several near-term milestones anticipated for our diversified pipeline this quarter we remain focused to our mission of creating new possibilities in mental health. https://www.biospace.com/drug-development/psychedelics-space-at-a-tipping-point-as-compass-definium-gear-up-to-file-for-approval"  
[X Link](https://x.com/ataibeckley/status/2018621310646055281)  2026-02-03T09:43Z 13.5K followers, [----] engagements


"We can change things. A future where families friends parents sons and daughters that we love have access to the help that they need. Its the only future we will accept. And today that future is one day closer"  
[X Link](https://x.com/anyuser/status/1405890111104036870)  2021-06-18T14:08Z 13.5K followers, [---] engagements


"Ring that bell @atai_life So much pride for this team. This is us ATAI on NASDAQ. We think it has a nice ring to it"  
[X Link](https://x.com/anyuser/status/1405934640087678980)  2021-06-18T17:05Z 13.5K followers, [---] engagements


"#News: atai Life Sciences $ATAI & @BeckleyPsytech announce results from the open-label Phase 2a study of BPL-003 in treatment-resistant depression. Read more: https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-report-positive-phase-2a https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-report-positive-phase-2a"  
[X Link](https://x.com/anyuser/status/1970444055311192406)  2025-09-23T11:04Z 13.5K followers, 112.6K engagements


"Interesting comments from @elonmusk at leading global tech conference #CODECON: "I think generally people should be open to psychedelics" #openyourmind #psychedelics $ATAI"  
[X Link](https://x.com/anyuser/status/1443646802511765505)  2021-09-30T18:39Z 13.5K followers, [---] engagements


"Today we announce our Series D fundraising successfully raising an additional $157m to progress our mission of healing mental health disorders. Read more: http://prn.to/38nH74j http://prn.to/38nH74j"  
[X Link](https://x.com/anyuser/status/1367149077796945920)  2021-03-03T16:25Z 13.5K followers, [---] engagements


"#News: atai Life Sciences & @BeckleyPsytech have combined to form atai Beckley Creating a global leader in psychedelic mental health therapies #mentalhealth therapies. Together were accelerating innovation for those in need. Learn more: Join our conference call at 8am ET: #ataibeckley #Biotech https://events.q4inc.com/attendee/298405838 https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-combine-creating-global https://events.q4inc.com/attendee/298405838"  
[X Link](https://x.com/ataibeckley/status/1929490755174662184)  2025-06-02T10:50Z 13.5K followers, 11.1K engagements


"What an incredible announcement from one of our strategic investments @COMPASSPathway Today COMPASS shared the news that the company has dosed the last patient in its phase 2b study Psilocybin Therapy for Treatment-Resistant Depression. https://compasspathways.com/psilocybin-therapy-216-patients/ https://compasspathways.com/psilocybin-therapy-216-patients/"  
[X Link](https://x.com/anyuser/status/1409876844606808083)  2021-06-29T14:10Z 13.5K followers, [--] engagements


"Today we announced positive initial results from Phase 1b of our VLS-01 program a proprietary oral formulation of DMT we are developing for an estimated [---] million people suffering from treatment-resistant #depression. The results support the potential of VLS-01 as best-in-class: a patient-friendly needle-free 2-hour in-clinic treatment. A robustly designed Phase [--] trial in [---] TRD patients is set to begin towards the end of this year"  
[X Link](https://x.com/anyuser/status/1823342164517982644)  2024-08-13T12:53Z 13.5K followers, [----] engagements


"AtaiBeckley lights up the @NASDAQ tower in Times Square The combination of atai Life Sciences & @BeckleyPsytech marks a major step forward for patients and the mental health care industry. Were excited for whats ahead and grateful to everyone who has supported us along the way. https://twitter.com/i/web/status/1986837549516792243 https://twitter.com/i/web/status/1986837549516792243"  
[X Link](https://x.com/anyuser/status/1986837549516792243)  2025-11-07T16:46Z 13.5K followers, [----] engagements


"Today all of us are extremely proud to share with you the closing of our Series C financing round. We believe that this reflects the growing recognition for more effective treatments in mental health. Plenty more to come in the future. 🙂 #mentalhealth https://www.prnewswire.com/news-releases/atai-life-sciences-announces-closing-of-125-million-series-c-financing-round-301178915.htmltc=eml_cleartime https://www.prnewswire.com/news-releases/atai-life-sciences-announces-closing-of-125-million-series-c-financing-round-301178915.htmltc=eml_cleartime"  
[X Link](https://x.com/anyuser/status/1330941962850013184)  2020-11-23T18:31Z 13.5K followers, [--] engagements


"Yesterday $atai filed a Form S-3. A shelf registration statement is ordinary course - replacing a previous shelf registration statement - we were also able to fulfill a contractual obligation to register (already issued) shares from the two private (previously closed) placements from June and July [----]. No new shares were issued as a result of this filing. https://twitter.com/i/web/status/1973029758817493269 https://twitter.com/i/web/status/1973029758817493269"  
[X Link](https://x.com/ataibeckley/status/1973029758817493269)  2025-09-30T14:18Z 13.5K followers, [----] engagements


"UPDATE: atai increases ownership in @COMPASSPathway to 20.8%. Demonstrating our strong confidence in COMPASS its milestone P2b #COMP360 #psilocybin data & its future in #psychedelics #mentalhealth #innovation See: https://bit.ly/atai-COMPASS-investment https://bit.ly/atai-COMPASS-investment"  
[X Link](https://x.com/anyuser/status/1465297756642320388)  2021-11-29T12:33Z 13.5K followers, [--] engagements


"2 weeks ago we celebrated our IPO a huge step for atai and an incredible team accomplishment. Our work continues with greater focus than ever so that everyone everywhere can live a more fulfilled life"  
[X Link](https://x.com/anyuser/status/1410908964599091201)  2021-07-02T10:31Z 13.5K followers, [--] engagements


"#News #Investors: Tackling the opioid use crisis requires bold innovation. Were proud to have been awarded a grant worth up to $11.4 million from @NIH to fund the development of novel treatment options. #MentalHealthInnovation @NIDAnews https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-awarded-grant-national-institutes-health https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-awarded-grant-national-institutes-health"  
[X Link](https://x.com/ataibeckley/status/1968717706946899990)  2025-09-18T16:44Z 13.5K followers, [----] engagements


"Congratulations @RickDoblin Amy Emerson and the entire team at @MAPS for submitting an NDA (New Drug Application) to the FDA for MDMA-assisted therapy for the treatment of PTSD. If approved this would be the first FDA-approved psychedelic-assisted therapy paving the way for the potential approval of other psychedelic-based treatments in the future. https://mapsbcorp.com/news/mdma-for-ptsd-fda-submission/ https://mapsbcorp.com/news/mdma-for-ptsd-fda-submission/"  
[X Link](https://x.com/anyuser/status/1734656836190495002)  2023-12-12T19:29Z 13.5K followers, [----] engagements


"Mental healthcare is likely the single largest unmet medical need in the world. Whats out there now isnt working. There are better options. Millions of people deserve these options. - @flobrand CEO and Co-Founder"  
[X Link](https://x.com/anyuser/status/1347906013022846981)  2021-01-09T14:00Z 13.5K followers, [--] engagements


"Announcing atai Impacts first initiative: the atai Fellowship Fund in Psychedelic Neuroscience with Massachusetts General Hospitals Center for the Neuroscience of Psychedelics. Driving critical #innovation to meet urgent #mentalhealth needs #ataiImpact @MassGeneralNews"  
[X Link](https://x.com/anyuser/status/1471459988623306755)  2021-12-16T12:39Z 13.5K followers, [--] engagements


"#News for #investors and #media: Topline results from our Phase 2b open-label extension study of BPL-003 in treatment-resistant depression support the safety and efficacy of a second dose. Read more: https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-announces-positive-topline-data-phase-2b-open-label https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-announces-positive-topline-data-phase-2b-open-label"  
[X Link](https://x.com/anyuser/status/1987854535801651547)  2025-11-10T12:07Z 13.5K followers, [----] engagements


"In response to the tragic events in Ukraine were donating $100k through our philanthropic fund atai Impact to @ICRC @SaveChildren @HelpAge & @LiberecoPHR towards emergency relief & supporting the #mentalhealth of the #Ukrainian people. #StandwithUkraine"  
[X Link](https://x.com/anyuser/status/1498625624361127941)  2022-03-01T11:46Z 13.5K followers, [--] engagements


"Q4 #Earnings highlights: Strong financial position following successful capital raise with two Phase [--] trials underway & large Phase 2b results expected mid-2025. 🔗 #MentalHealth http://bit.ly/4ioeENc http://bit.ly/4ioeENc"  
[X Link](https://x.com/anyuser/status/1901609732940444021)  2025-03-17T12:21Z 13.5K followers, [----] engagements


"We are pleased to announce positive topline results from our Phase [--] EMP-01 (R-MDMA) study. We found differences in the subjective experience of R-MDMA in comparison to published reports involving racemic MDMA. If confirmed these differences suggest that R-MDMA may have applicability in a broad array of mental health conditions said Dr. @SriniGRao Chief Scientific Officer and Co-Founder of atai. Full release: https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-positive-topline-results-single"  
[X Link](https://x.com/anyuser/status/1742238780277330425)  2024-01-02T17:37Z 13.5K followers, [----] engagements


"Today we received approvals to initiate the Phase [--] trial of EMP-01 an MDMA derivative being developed for the treatment of #PTSD Phase [--] is a critical first step in establishing safety & tolerability. We look forward to results expected in H2 [----] https://bit.ly/3ram1z5 https://bit.ly/3ram1z5"  
[X Link](https://x.com/anyuser/status/1574822837155762185)  2022-09-27T18:06Z 13.5K followers, [--] engagements


"Cognitive Impairment Associated with Schizophrenia is a debilitating disorder with no effective treatments. We proudly announce a step towards bridging that gap as Recognify initiates a Phase 2a study after receiving IND clearance. Read more: https://prn.to/3t1dXA4 https://prn.to/3t1dXA4"  
[X Link](https://x.com/anyuser/status/1379553314531053572)  2021-04-06T21:55Z 13.5K followers, [--] engagements


"Today we announced the initiation of a Phase [--] clinical trial of intranasal INB-01 a sol-gel based direct-to-brain drug-delivery technology. Topline results are expected in H1 [----]. #mentalhealth #biotech #innovation https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-initiation-phase-1-proof-concept https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-initiation-phase-1-proof-concept"  
[X Link](https://x.com/anyuser/status/1582340812436049923)  2022-10-18T12:00Z 13.5K followers, [--] engagements


"Following promising interim data from our RL-007 P2a trial in Cognitive Impairment Associated with Schizophrenia we are supporting acceleration of its clinical development. Press release: #schizophrenia #mentalhealth #clinicaltrials https://bit.ly/Recognify-Interim-Data-Ph2a https://bit.ly/Recognify-Interim-Data-Ph2a"  
[X Link](https://x.com/anyuser/status/1455158187368361986)  2021-11-01T13:02Z 13.5K followers, [--] engagements


"Congratulations to our strategic investment @COMPASSPathways on announcing a multi-year partnership with @KingsIoPPN and @MaudsleyNHS. Collabs like this are key as we work towards better care for mental health. https://compasspathways.com/kings-college-london-south-london-and-maudsley/ https://compasspathways.com/kings-college-london-south-london-and-maudsley/"  
[X Link](https://x.com/anyuser/status/1412552743697453062)  2021-07-06T23:23Z 13.5K followers, [--] engagements


"#Q2 [----] highlights: ✅Announced atais strategic combination with @BeckleyPsytech ✅Reported positive topline data in BPL-003 for treatment-resistant depression Full update: #MentalHealth #Biotech #Earnings https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-reports-second-quarter-2025-financial-results https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-reports-second-quarter-2025-financial-results"  
[X Link](https://x.com/anyuser/status/1955989770418708820)  2025-08-14T13:47Z 13.5K followers, [----] engagements


"#Q3 2025: a transformational quarter for AtaiBeckley Highlights: ✅ BPL-003 received Breakthrough Therapy designation by the U.S. FDA for treatment-resistant depression ✅Reported positive Phase 2a and Phase 2b open-label extension data for BPL-003 Full update: #Q3 #Earnings https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-reports-third-quarter-2025-financial-results-and https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-reports-third-quarter-2025-financial-results-and"  
[X Link](https://x.com/anyuser/status/1988578780412367262)  2025-11-12T12:05Z 13.5K followers, 10.6K engagements


"At atai our motivation is personal. Our CEO @flobrand has a personal connection and motivation that inspired his commitment to improving treatments for mental health disorders. Like Florian were all committed professionally and personally"  
[X Link](https://x.com/anyuser/status/1405881930432790528)  2021-06-18T13:35Z 13.5K followers, [--] engagements


"Our Founder & Chairman @C_Angermayer is talking today at renowned US @SALTConference - testament to the growing psychedelic renaissance & broadening interest in the potential of #psychedelics in the future of #mentalhealth treatment. #OpenYourMind #ApeironInvestments"  
[X Link](https://x.com/anyuser/status/1437737956601704450)  2021-09-14T11:20Z 13.5K followers, [--] engagements


"We are thrilled to announce the first subject dosed in our Phase [--] trial for buccal and IV VLS-01 a form of #DMT for the relief of treatment-resistant depression #TRD. Topline results expected in H1 [----]. https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-first-subject-dosed-phase-1-trial https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-first-subject-dosed-phase-1-trial"  
[X Link](https://x.com/anyuser/status/1577629915201126407)  2022-10-05T12:00Z 13.5K followers, [--] engagements


"Our vision is clear. We work so that everyone everywhere can live a more fulfilled life"  
[X Link](https://x.com/anyuser/status/1405880575962009601)  2021-06-18T13:30Z 13.5K followers, [--] engagements


"Today we announced the initiation of a Phase 2b proof-of-concept clinical trial of RL-007 for Cognitive Impairment Associated with #Schizophrenia for which there are currently no @US_FDA-approved treatments. cc @flobrand @C_Angermayer sub #mentalhealth https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-initiates-phase-2b-proof-concept-trial-rl-007 https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-initiates-phase-2b-proof-concept-trial-rl-007"  
[X Link](https://x.com/anyuser/status/1604829394660229121)  2022-12-19T13:21Z 13.5K followers, [----] engagements


"Excited to announce initial results from @BeckleyPsytech's Phase 2a open label study of BPL-003 (intranasal 5-MeO-DMT) in patients who suffer from treatment-resistant depression (TRD). The results offer encouraging support for a 2-hour psychedelic-based treatment in the clinic. In summary the Phase 2a results of BPL-003 demonstrated: [--]. Rapid-acting relief: a single dose of BPL-003 demonstrated a rapid antidepressant response in over half of the patients offering hope for the [---] million grappling with the burden of TRD globally. 2.Durable antidepressant effect: 45% of patients were in"  
[X Link](https://x.com/anyuser/status/1772949013517475895)  2024-03-27T11:29Z 13.5K followers, [----] engagements


"A little history of #psilocybin to put todays news our increased stake in @COMPASSPathway in context. #COMP360 #psychedelics #mentalhealth"  
[X Link](https://x.com/anyuser/status/1465459450630881284)  2021-11-29T23:15Z 13.5K followers, [--] engagements


"Milestone update: Enrollment complete in Ph2b trial of @BeckleyPsytech's BPL-003 for treatment-resistant depression (TRD). Results expected mid-2025. Full announcement here: http://bit.ly/4immzun http://bit.ly/4immzun"  
[X Link](https://x.com/anyuser/status/1897277094629138585)  2025-03-05T13:24Z 13.5K followers, [----] engagements


"Thrilled to announce our strategic investment in and collaboration with @BeckleyPsytech bringing two clinical-stage psychedelic assets into the atai mental health innovation platform. Join the webcast with our executive team today at 8am ET today to learn more. Full press release here: https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-strategic-investment-beckley https://edge.media-server.com/mmc/p/astec47k/ https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-strategic-investment-beckley"  
[X Link](https://x.com/anyuser/status/1742892851275423847)  2024-01-04T12:56Z 13.5K followers, [----] engagements


"ICYMI: Last week we announced a strategic investment in @BeckleyPsytech underscoring our conviction in psychedelics to transform the landscape of mental health treatments. As covered by Bloomberg the deal brings two patent-protected clinical-stage short-duration psychedelic assets into the atai platform reinforcing our #psychedelics portfolio as the largest and most diverse in biopharma. https://www.bloomberg.com/news/articles/2024-01-04/thiel-backed-psychedelic-firm-atai-said-to-buy-stake-in-beckley"  
[X Link](https://x.com/anyuser/status/1744370808745533524)  2024-01-08T14:49Z 13.5K followers, [----] engagements


"#News: Were thrilled to announce the successful completion of atai Life Sciences strategic combination with Beckley Psytech. Together we are now AtaiBeckley a global leader in transformative mental health therapies. Read the press release here: https://ir.ataibeckley.com/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-announce-successful https://ir.ataibeckley.com/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-announce-successful"  
[X Link](https://x.com/anyuser/status/1986042290083958930)  2025-11-05T12:05Z 13.5K followers, 17.2K engagements


"Our platform company Perception Neuroscience & Otsuka Pharmaceuticals join forces to develop & commercialize PCN-101 in Japan PCN-101 is a formulation of R-ketamine being developed as a rapid acting antidepressant for potential at home use. Read more: http://prn.to/3rWqiF2 http://prn.to/3rWqiF2"  
[X Link](https://x.com/anyuser/status/1371871421396348938)  2021-03-16T17:10Z 13.5K followers, [--] engagements


"Kicking off [----] with a strengthened leadership team: Srinivas Rao leads as sole CEO Kevin Craig promoted to CMO Glenn Short promoted to CSO Gerd Kochendoerfer joins as COO. With VLS-01 & EMP-01 entering Phase [--] & BPL-003 data anticipated in Q2 were advancing novel #psychedelic therapies for #mentalhealth. Read more: https://buff.ly/4h9OY66 https://buff.ly/4h9OY66"  
[X Link](https://x.com/anyuser/status/1877740379065246100)  2025-01-10T15:32Z 13.5K followers, [----] engagements


"Big news from our partners @IntelGenx Huge congratulations on FDA approval - it's fantastic to see this innovative technology being used by those in need. Can't wait to see how what we'll accomplish together with our VLS-01 oral thin film formulation of DMT for the potential treatment of major depressive disorder. https://www.contractpharma.com/contents/view_breaking-news/2023-04-13/intelgenx-announces-organizational-changes/ https://www.contractpharma.com/contents/view_breaking-news/2023-04-13/intelgenx-announces-organizational-changes/"  
[X Link](https://x.com/anyuser/status/1648026959392174086)  2023-04-17T18:13Z 13.5K followers, [----] engagements


"Redefining how the world approaches prevents and heals #mentalhealth disorders. Our mission is to bridge the gap between what the mental healthcare system currently provides and what patients need. @C_Angermayer @flobrand @SriniGRao @peterthiel @novogratz @FutureJurvetson"  
[X Link](https://x.com/anyuser/status/1331644879781437442)  2020-11-25T17:04Z 13.5K followers, [--] engagements


"Today we announced the results from the Phase [--] intravenous-to-subcutaneous bridging study of PCN-101 (R-ketamine). Read more: #MentalHealth #Biotech #CollaborativeInnovation https://lnkd.in/d4j7uH7U https://lnkd.in/d4j7uH7U"  
[X Link](https://x.com/anyuser/status/1689005410341265408)  2023-08-08T20:07Z 13.5K followers, [----] engagements


"Read our latest white paper in @Nature chronicling the modern history of #psychedelics their potential efficacy in solving the #mentalhealth crisis and the path forward for moving from clinical trials through to patient access. https://www.nature.com/articles/d42473-022-00380-y https://www.nature.com/articles/d42473-022-00380-y"  
[X Link](https://x.com/anyuser/status/1575196115070517248)  2022-09-28T18:49Z 13.5K followers, [--] engagements


"Today we announced our Q2 [----] earnings: - Extended runway into [----] - $312m cash + up to $175m non-dilutive debt - Reprioritized pipeline w/ focus on clinical programs - Hit [--] key R&D milestones and many expected PoC readouts in next [--] years https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-reports-second-quarter-2022-financial-results https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-reports-second-quarter-2022-financial-results"  
[X Link](https://x.com/anyuser/status/1559149623167655936)  2022-08-15T12:06Z 13.5K followers, [--] engagements


"Were working to overcome the challenges of drug delivery for the treatment of mental health disorders. Watch to learn more about our enabling tech company InnarisBio with @UniQuestUQ and our sol-gel intranasal drug delivery platform"  
[X Link](https://x.com/anyuser/status/1420406190882783234)  2021-07-28T15:30Z 13.5K followers, [--] engagements


"📣 BPL-003 clinical trial progress A few weeks ago we announced the positive results from the BPL-003 Phase 2a study in patients with treatment resistant depression who were not on oral antidepressants (SSRIs). The first patient has now been dosed in the second part of the Phase 2a study in patients who are on SSRIs which could help to inform whether BPL-003 could be a safe and effective therapy in combination with SSRIs. Read the full release here: https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-dosing-first-patient-part-2-beckley"  
[X Link](https://x.com/anyuser/status/1783089804512505935)  2024-04-24T11:05Z 13.5K followers, [----] engagements


"Today we announced results from the Kures Therapeutics Phase [--] Part [--] clinical trial of KUR-101 a deuterated derivative of mitragynine for the potential treatment of #opioidusedisorder cc @flobrand @C_Angermayer @Allan_Malievsky sub #mentalhealth #oud https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-results-kures-therapeutics-phase-1 https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-results-kures-therapeutics-phase-1"  
[X Link](https://x.com/anyuser/status/1606276895565402118)  2022-12-23T13:13Z 13.5K followers, [----] engagements


"📣 Exciting update on @BeckleyPsytech's Phase 1/2a trial of ELE-101 (IV psilocin) for major depression. Initial results from Phase [--] and first patients dosed in Phase 2a. Full press release: https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-update-beckley-psytechs-phase-12a https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-update-beckley-psytechs-phase-12a"  
[X Link](https://x.com/anyuser/status/1803745279474053402)  2024-06-20T11:02Z 13.5K followers, [----] engagements


"Our Co-Founder & Chairman @C_Angermayer is the headline act today at the Grizzle Psychedelics Conference speaking at 10:50 ET telling the story & vision of @atai_life front & center in the #psychedelics #mentalhealth renaissance. See more: https://grizzle.com/psychedelicscon-nov-2021/ https://grizzle.com/psychedelicscon-nov-2021/"  
[X Link](https://x.com/anyuser/status/1462755336201424896)  2021-11-22T12:10Z 13.5K followers, [--] engagements


"Want to keep up with the ATAI team on Twitter Let's connect @flobrand CEO @SriniGRao CSO @Roman_Dahl Operations Lead @DannyTalati BD Lead @gregulatory Regulatory Lead @ph_schreiber BD @SimonSeibold BD @Allan_Malievsky Comms #psychedelics #mentalhealth #TogetherAtHome"  
[X Link](https://x.com/anyuser/status/1248639120265674752)  2020-04-10T15:48Z 13.5K followers, [--] engagements


"Mental health disorders such as depression substance use disorder and anxiety which are among our initial indications of focus are highly prevalent and estimated to affect more than one billion people globally"  
[X Link](https://x.com/anyuser/status/1405881398771294216)  2021-06-18T13:33Z 13.5K followers, [--] engagements


"HUGE ANNOUNCEMENT: This will accelerate our research into the therapeutic potential of psychedelics Were thrilled to announce our collaboration with @MassGeneralNews and their newly established Center for the Neuroscience of Psychedelics. Read more: http://prn.to/2YiZuBL http://prn.to/2YiZuBL"  
[X Link](https://x.com/anyuser/status/1354409107592273921)  2021-01-27T12:41Z 13.5K followers, [--] engagements


"Congratulations @COMPASSPathway As an early and significant shareholder in the company we are pleased leading healthcare investors are supporting mental health psychedelic medicine and interventional psychiatry. Read more: https://compasspathways.com/compass-pathways-announces-up-to-285-million-private-placement-financing-joined-by-leading-healthcare-investors-2/ https://compasspathways.com/compass-pathways-announces-up-to-285-million-private-placement-financing-joined-by-leading-healthcare-investors-2/"  
[X Link](https://x.com/anyuser/status/1692205587071737985)  2023-08-17T16:03Z 13.5K followers, [----] engagements


"#ICYMI: Last week we announced positive results from our Phase [--] clinical trial of GRX-917 for generalized anxiety disorder (GAD). Initiation of GRX-917 efficacy study is anticipated in H1 [----] with results expected in [----]. https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-company-gaba-therapeutics-announces-positive https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-company-gaba-therapeutics-announces-positive"  
[X Link](https://x.com/anyuser/status/1615756832940621847)  2023-01-18T17:03Z 13.5K followers, [----] engagements


"Today we announced our Q1 [----] #earnings. Read about the progress weve made across our [--] key pillars to deliver on our vision to achieve clinically meaningful behavioral change in people living with #mentalhealth disorders $ATAI https://bit.ly/atai_Q12022 https://bit.ly/atai_Q12022"  
[X Link](https://x.com/anyuser/status/1526156067109015552)  2022-05-16T11:02Z 13.5K followers, [--] engagements


"Today we announced the completion of the Phase [--] study of VLS-01 (DMT) in healthy participants. Our CEO and Co-Founder @Flobrand commented: We are pleased to report the completion of the Phase [--] study of VLS-01 in which we demonstrated a supportive PK/PD profile of our proprietary OTF formulation of DMT. We plan to test a further optimized version of our OTF formulation in a forthcoming Phase 1b prior to initiating a Phase [--] study in TRD. Read more: #Biotech #MentalHealth https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-completion-phase-1-study-vls-01"  
[X Link](https://x.com/anyuser/status/1708940640321462489)  2023-10-02T20:22Z 13.5K followers, [----] engagements


"Today we announced our [----] EOY & Q4 #earnings. $ATAI #mentalhealth #biotech Full release: https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-reports-fourth-quarter-and-full-year-2022 https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-reports-fourth-quarter-and-full-year-2022"  
[X Link](https://x.com/anyuser/status/1639279605000314880)  2023-03-24T14:54Z 13.5K followers, [----] engagements


"Today we announced the completion of enrollment for a Phase 2a clinical trial of PCN-101 (R-ketamine) a stereoisomer of #ketamine for treatment-resistant #depression (TRD). To learn more make sure you join our virtual R&D Day today @ 12pm ET https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-company-perception-neuroscience-completes https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-company-perception-neuroscience-completes"  
[X Link](https://x.com/anyuser/status/1584880750972661762)  2022-10-25T12:13Z 13.5K followers, [--] engagements


"Our team has made excellent progress this quarter on our #clinical programs. ✔Announced Phase 1b results for VLS-01 (oral buccal film DMT) with a Phase [--] study in [---] patients with treatment-resistant #depression expected to initiate around year end. See our new corporate presentation linked below for a deep dive into the data. ✔ Announced clinical development plans for EMP-01 (oral R-MDMA) and expect to initiate a Phase [--] study in social anxiety disorder (SAD) later this year. This follows encouraging Phase [--] results where EMP-01 demonstrated a unique subjective profile compared to racemic"  
[X Link](https://x.com/anyuser/status/1823373662298288542)  2024-08-13T14:58Z 13.5K followers, [----] engagements


"Ketamine has been used for everything from anesthesia and sedation to chronic pain and severe treatment resistant depression"  
[X Link](https://x.com/anyuser/status/1439967233694965762)  2021-09-20T14:58Z 13.5K followers, [--] engagements


"1 in [--] people globally will be diagnosed with a #mentalhealth disorder before they reach the age of [--]. With this in mind today we shared our Q2 [----] financial results and business highlights which demonstrate progress towards our mission of pioneering the development of the next generation of #mentalhealthtreatments that address the unmet needs of patients. #MentalHealth #Biotech #EveryoneEverywhere #Q2 #Earnings"  
[X Link](https://x.com/anyuser/status/1689595310996144128)  2023-08-10T11:11Z 13.5K followers, [----] engagements


"Today were pleased to share that the first patient has been dosed in our VLS-01 Phase 1b trial. VLS-01 is being developed as a rapid-acting and durable antidepressant treatment intervention for people suffering from treatment resistant depression a condition which affects approximately [---] million people globally. We expect topline results for this study in the second half of this year. Read more: https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-first-participant-dosed-phase-1b"  
[X Link](https://x.com/anyuser/status/1764648420248109413)  2024-03-04T13:45Z 13.5K followers, [----] engagements


"MAJOR NEWS: A new addition to the atai family Were thrilled to announce that we have acquired a majority stake in Recognify Life Sciences focused on developing a treatment for Cognitive Impairment associated with Schizophrenia (CIAS). (Read more below.)"  
[X Link](https://x.com/anyuser/status/1351151310796677123)  2021-01-18T12:55Z 13.5K followers, [--] engagements


"In England antidepressant usage has hit an all-time high. But they are far from a one-size-fits-all solution. SSRIs take anywhere from [--] weeks to [--] months + to have an effect. And often time isn't something that those battling with their mental health have in abundance"  
[X Link](https://x.com/anyuser/status/1348266099251544064)  2021-01-10T13:51Z 13.5K followers, [--] engagements


"In the US anxiety disorders affect approximately [--] million adults or 18% of the population. Only around a third of these people receive any treatment. Without treatment most anxiety disorders persist indefinitely. Addressing this problem has never been more important"  
[X Link](https://x.com/anyuser/status/1356240962624888832)  2021-02-01T14:00Z 13.5K followers, [--] engagements


"Announcing initiation of Phase 1/2a trial testing ibogaine for the treatment of opioid use disorder (OUD). Learn more about this naturally-occurring psychedelic isolated from a West African shrub. Press release: #OpioidUseDisorder #ibogaine $ATAI https://bit.ly/atai-DemeRx-Ph1-2a https://bit.ly/atai-DemeRx-Ph1-2a"  
[X Link](https://x.com/anyuser/status/1440289116533317633)  2021-09-21T12:17Z 13.5K followers, [--] engagements


"Apeiron Investment Group & other key pre-IPO investors have shown their strong confidence in @atai_Life extending the lock-up on approx. 30% of overall equity. Clear demonstration of their shared belief in our vision & our ability to achieve it. Read: https://bit.ly/atai-lock-up https://bit.ly/atai-lock-up"  
[X Link](https://x.com/anyuser/status/1471089905841455109)  2021-12-15T12:08Z 13.5K followers, [--] engagements


"#ICYMI: @thetimes' Science Editor @Ben_Spencer wrote a special report on #mentalhealth & #psychedelics Between atai and @COMPASS the two companies have eight compounds in clinical trials from MDMA -derivative and ibogaine to dimethyltryptamine. https://www.thetimes.co.uk/article/psychedelic-drugs-mental-health-help-magic-mushrooms-93rf58stg https://www.thetimes.co.uk/article/psychedelic-drugs-mental-health-help-magic-mushrooms-93rf58stg"  
[X Link](https://x.com/anyuser/status/1598335410022846465)  2022-12-01T15:17Z 13.5K followers, [--] engagements


"Gem from @andersoncooper & @michaelpollan in recent @60Minutes on #psychedelics: "Pollan experienced what researchers describe as ego loss or identity loss (.) AC: And what are you are without an ego MP: You're uh You had to be there." https://www.cbsnews.com/news/psychedelic-drugs-lsd-active-agent-in-magic-mushrooms-to-treat-addiction-depression-anxiety-60-minutes-2019-10-13/ https://www.cbsnews.com/news/psychedelic-drugs-lsd-active-agent-in-magic-mushrooms-to-treat-addiction-depression-anxiety-60-minutes-2019-10-13/"  
[X Link](https://x.com/anyuser/status/1184140829536993286)  2019-10-15T16:15Z 13.5K followers, [--] engagements


"DATA ALERT: #COMP360 #psilocybin P2b data show rapid & durable effects in TRD. Major news for @COMPASSPathway atai & patients. Congratulations @LarsWilde Ekaterina Malievskaia George Goldsmith & team. See: #mentalhealth #psychedelics https://bit.ly/CMPS-Ph2b-data https://bit.ly/CMPS-Ph2b-data"  
[X Link](https://x.com/anyuser/status/1458097798323359748)  2021-11-09T15:42Z 13.5K followers, [--] engagements


"Congratulations to @COMPASSPathway on their latest publication in @JAMAPsych detailing the results of COMP360 psilocybin treatment in bipolar type II depression. These early efficacy signals for such a hard-to-treat indication are encouraging. https://compasspathways.com/study-results-of-psilocybin-treatment-in-bipolar-ii-depression-published-in-jama-psychiatry/ https://compasspathways.com/study-results-of-psilocybin-treatment-in-bipolar-ii-depression-published-in-jama-psychiatry/"  
[X Link](https://x.com/anyuser/status/1732790195445989560)  2023-12-07T15:52Z 13.5K followers, [----] engagements


"Our CEO and Co-Founder @flobrand spoke to @amanda_siebert @Forbes to give deeper context on the significance of our donation to @MAPS and the importance of collaboration between for-profit and non-profits in tackling the #mentalhealth crisis. See: https://www.forbes.com/sites/amandasiebert/2022/02/16/exclusive-maps-accepts-500k-donation-from-atai-life-sciences-philanthropy-arm/ https://www.forbes.com/sites/amandasiebert/2022/02/16/exclusive-maps-accepts-500k-donation-from-atai-life-sciences-philanthropy-arm/"  
[X Link](https://x.com/anyuser/status/1494014479981596678)  2022-02-16T18:23Z 13.5K followers, [--] engagements


"Marking #WorldMentalHealthDay by highlighting mental health issues for refugees and the displaced people around the world - people who have higher rates of mental health challenges because of the trauma they have faced but less access to quality care"  
[X Link](https://x.com/anyuser/status/1447215609587056642)  2021-10-10T15:01Z 13.5K followers, [--] engagements


"Every day over [---] million people face the struggle of depression. [--] in [--] find no relief in current treatment options. For those living with treatment-resistant depression hope feels out of reach. We're proud to share the next video in our #OneBillionPeople series highlighting the challenges of living with TRD. #MentalHealth"  
[X Link](https://x.com/anyuser/status/1854154406029078907)  2024-11-06T13:30Z 13.5K followers, [----] engagements


"Today our co-founder and CSO @SriniGRao will give testimony alongside other experts on the scientific data of ibogaine as a potential treatment option for Opioid Use Disorder (OUD) behalf of the Kentucky Opioid Abatement Advisory Commission. The Commissions goal is to allocate up to $42 million over six years towards research into the treatment of OUD specifically looking into ibogaine. We couldnt be prouder of Srini for speaking up and advocating on behalf of those who need new and effective treatment options. Tune in at 2pm EST 👇 https://www.youtube.com/watchv=WuOpoyITuqA"  
[X Link](https://x.com/anyuser/status/1680922434009026561)  2023-07-17T12:48Z 13.5K followers, [----] engagements


"We are pleased to share our Q3 [----] update demonstrating the progress weve made in pursuit of our mission to heal mental health disorders. We advanced our key clinical programs such as RL-007 VLS-01 and EMP-01 and continued to drive forward our drug discovery and preclinical work such as on our EG-X compounds. With a strong cash balance of $209M and our dedicated team we are well-positioned to continue advancing our programs towards upcoming milestones. Read more: $ATAI #MentalHealth #Biotech #MentalHealthResarch #Q3 #Earnings"  
[X Link](https://x.com/anyuser/status/1724399728425570775)  2023-11-14T12:11Z 13.5K followers, [----] engagements


"People with treatment-resistant depression urgently need better options. PsyProtix will take a precision psychiatry approach utilizing metabolomics to analyze diet exposome gut microbiome & genome to potentially tailor treatments to individuals. https://bit.ly/atai-PsyProtix-launch https://bit.ly/atai-PsyProtix-launch"  
[X Link](https://x.com/anyuser/status/1447540185185533955)  2021-10-11T12:30Z 13.5K followers, [--] engagements


"Thank you @52_Insights for hosting @flobrand & @C_Angermayer. This is the first time the two have appeared on a podcast together which certainly makes for a fascinating conversation Listen here: https://www.52-insights.com/podcast-interview-a-higher-calling-florian-brand-christian-angermayer-atai/ https://www.52-insights.com/podcast-interview-a-higher-calling-florian-brand-christian-angermayer-atai/"  
[X Link](https://x.com/anyuser/status/1434888833745788934)  2021-09-06T14:38Z 13.5K followers, [--] engagements


"Just in: post-hoc analyses of #COMP360 P2b in TRD by @COMPASSPathway show further improvements in key areas central to #patient recovery: #anxiety self-reported #depression positive & negative affect functioning & quality of life. Congrats again to all https://bit.ly/3FYL11E https://bit.ly/3FYL11E"  
[X Link](https://x.com/anyuser/status/1466060132916285440)  2021-12-01T15:02Z 13.5K followers, [--] engagements


"A historic milestone by the @COMPASSPathway team @NEJM has published positive results from COMPASS phase 2b trial of COMP360 #psilocybin therapy for treatment-resistant #depression Congratulations from everyone at atai 👏👏👏 https://compasspathways.com/compass-pathways-announces-publication-of-phase-2b-study-of-comp360-psilocybin-therapy-for-treatment-resistant-depression-in-the-new-england-journal-of-medicine/"  
[X Link](https://x.com/anyuser/status/1588223105696006144)  2022-11-03T17:34Z 13.5K followers, [--] engagements


"This long-anticipated report from @PierceARK (via @CathieDWood's @ARKInvest) skillfully balances excitement re #psychedelics with a #biotech-focused analysis of the road ahead. Grateful to the ARK team for helping educate the public #mentalhealth https://ark-invest.com/articles/analyst-research/psychedelic-therapeutics/ https://ark-invest.com/articles/analyst-research/psychedelic-therapeutics/"  
[X Link](https://x.com/anyuser/status/1565399176850116610)  2022-09-01T18:00Z 13.5K followers, [--] engagements


"Today we launch Invyxis our latest addition to our suite of complementary tech for #psychedelic and nonpsychedelic drug discovery to continue to pioneer next gen #mentalheath treatments for patients in need. https://bit.ly/atai-launches-Invyxis https://bit.ly/atai-launches-Invyxis"  
[X Link](https://x.com/anyuser/status/1486676485247283203)  2022-01-27T12:24Z 13.5K followers, [--] engagements


"Q3 #Earnings update: IND cleared for VLS-01 with Phase [--] in TRD initiating around YE24. Also on track for Phase [--] study of EMP-01 in SAD. Exciting momentum as we drive mental health innovation forward. Full press release: https://buff.ly/3UKSBqI https://buff.ly/3UKSBqI"  
[X Link](https://x.com/anyuser/status/1856698579433447469)  2024-11-13T14:00Z 13.5K followers, [----] engagements


"A growing number of ex-troops are experiencing the healing power of #psychedelics. I believe I left my PTSD behind in those sessions. I am no longer destructive or closed off. I have my life back. By Jamie Doward for @guardian. #psilocybin #PTSD https://www.theguardian.com/uk-news/2020/jul/04/magic-mushrooms-could-help-ex-soldiers-to-overcome-trauma https://www.theguardian.com/uk-news/2020/jul/04/magic-mushrooms-could-help-ex-soldiers-to-overcome-trauma"  
[X Link](https://x.com/anyuser/status/1280146991675301888)  2020-07-06T14:30Z 13.5K followers, [--] engagements


"Boston-based grad students can now apply for the atai Fellowship in Psychedelic Neuroscience at @MassGeneralNews. Fellows will investigate the potential of #psychedelics to improve 🧠 health and address the #mentalhealth crisis. More info: #ataiImpact https://www.massgeneral.org/psychiatry/education-and-training/neuroscience-psychedelics-atai-fellowship https://www.massgeneral.org/psychiatry/education-and-training/neuroscience-psychedelics-atai-fellowship"  
[X Link](https://x.com/anyuser/status/1529519563360067585)  2022-05-25T17:47Z 13.5K followers, [--] engagements


"Today we announced our [----] EOY & Q4 #earnings. [----] was a transformative year for atai. This positive momentum continues through [----] & beyond. We are very well positioned to deliver on our vision: to heal #mentalhealth disorders $ATAI 1/2 https://bit.ly/atai-earnings https://bit.ly/atai-earnings"  
[X Link](https://x.com/anyuser/status/1509132334238470146)  2022-03-30T11:36Z 13.5K followers, [--] engagements


"Were excited to announce the initiation of a clinical study with @MassGeneralNews to develop a novel method to detect #neuroplasticity in patients with #TRD undergoing IV #ketamine treatment. https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-and-massachusetts-general-hospital-announce https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-and-massachusetts-general-hospital-announce"  
[X Link](https://x.com/anyuser/status/1593240072090185730)  2022-11-17T13:50Z 13.5K followers, [--] engagements


"Has COVID-19 magnified depression Yes based on surveys depression symptoms have increased 3X since the beginning of the COVID-19 pandemic and severe depression symptoms have increased 7.5x"  
[X Link](https://x.com/anyuser/status/1438527385305903106)  2021-09-16T15:37Z 13.5K followers, [--] engagements


"Were proud to support @MGHNeurology and their Center for the Neuroscience of Psychedelics. The atai Research #Fellowship is designed to help graduate students pursue cutting-edge research in mental health. #MentalHealthInnovation https://www.youtube.com/watchv=5BsVrWbWYYk https://www.youtube.com/watchv=5BsVrWbWYYk"  
[X Link](https://x.com/ataibeckley/status/1958933356512780671)  2025-08-22T16:44Z 13.5K followers, [----] engagements


"So proud to welcome another member of the ATAI family: Viridia developing N N-Dimethyltryptamine (#DMT) We sat down w/ @amirahalidrus of @FierceBiotech to share more about the potential of rapid-acting #psychedelics for #mentalhealth https://www.fiercebiotech.com/biotech/meet-viridia-atai-unit-exploring-ayahuasca-based-treatments-for-mental-illness https://www.fiercebiotech.com/biotech/meet-viridia-atai-unit-exploring-ayahuasca-based-treatments-for-mental-illness"  
[X Link](https://x.com/anyuser/status/1285968435445465089)  2020-07-22T16:02Z 13.5K followers, [--] engagements


"COMPANY UPDATES [--] FPI in Ph2 study of RL-007 for CIAS [--] Development plan to progress GRX-917 for #anxiety directly into Ph2 [--] Acceleration of CMPS Ph3 #psilocybin program [--] Pipeline updates to extend runway into [----] #mentalhealth #biotech https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-key-clinical-pipeline-and-corporate https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-key-clinical-pipeline-and-corporate"  
[X Link](https://x.com/anyuser/status/1632831216998031361)  2023-03-06T19:51Z 13.5K followers, [----] engagements


"Love this panel :) @shelbyannehart/@doubleblindmag injecting nuance as always and reminds us to be mindful that (nomatter where you fit on decrim/legalization/medicalization continuum) we in the #psychedelics community may be in a bit of a bubble (however large) 💭 @MicrodoseHQ"  
[X Link](https://x.com/anyuser/status/1250153194350665728)  2020-04-14T20:05Z 13.5K followers, [--] engagements


"Welcome to all our new followers Sign up to our #InsightNetwork where you can keep up with the latest events and news in biotech #mentalhealth research and #psychedelic science. Sign up: Read: LinkedIn: https://www.linkedin.com/company/atai-life-sciences/viewAsMember=true https://us18.campaign-archive.com/home/u=bbad3a00b103f46e4fc6e71d3&id=e255a03cd1 https://life.us18.list-manage.com/subscribeu=bbad3a00b103f46e4fc6e71d3&id=e255a03cd1 https://www.linkedin.com/company/atai-life-sciences/viewAsMember=true https://us18.campaign-archive.com/home/u=bbad3a00b103f46e4fc6e71d3&id=e255a03cd1"  
[X Link](https://x.com/anyuser/status/1331287050876825625)  2020-11-24T17:22Z 13.5K followers, [--] engagements


"Half of the worlds population will experience a mental health condition in their lifetime. This staggering statistic underscores the pressing need for innovative new approaches to both preventing and treating mental conditions. That's why we're dedicated to developing new treatment options for conditions such as treatment-resistant depression opioid use disorder and schizophrenia"  
[X Link](https://x.com/anyuser/status/1777362237591617826)  2024-04-08T15:45Z 13.5K followers, [----] engagements


"We were saddened to learn of the recent passing of Roland Griffiths Ph.D. Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine. Dr. Griffiths leaves behind an unparalleled legacy of clinical trials and published papers. His groundbreaking research into psychedelic medicine has laid the foundations for the work we do today at atai and for the innovations that are yet to come in treating mental health"  
[X Link](https://x.com/anyuser/status/1714611294639108350)  2023-10-18T11:56Z 13.5K followers, [----] engagements


"Inspired by this @MayoClinic article highlighting the misunderstanding and stigma that can make it difficult for people to seek mental health care we got thinking about some of the ways we can take care of our mental well-being. Here are [--] simple things you can start implementing now. #mentalhealth #depression #WellnessJourney https://mcpress.mayoclinic.org/major-depressive-disorder/depression-supporting-yourself/ https://mcpress.mayoclinic.org/major-depressive-disorder/depression-supporting-yourself/"  
[X Link](https://x.com/anyuser/status/1755650783947702370)  2024-02-08T17:52Z 13.5K followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing